We are live on ! Find out more
CORT icon

Corcept Therapeutics
CORT

239 hedge funds and large institutions have $2.24B invested in Corcept Therapeutics in 2022 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 91 increasing their positions, 78 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 19

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

17% more repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 78

11% more capital invested

Capital invested by funds: $2.02B → $2.24B (+$218M)

6% more funds holding

Funds holding: 225 → 239 (+14)

2.6% more ownership

Funds ownership: 79.03% → 81.63% (+2.6%)

8% less call options, than puts

Call options by funds: $8.13M | Put options by funds: $8.8M

Holders
239
Holders Change
+14
Holders Change %
+6.22%
% of All Funds
4.12%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
35
Increased
91
Reduced
78
Closed
19
Calls
$8.13M
Puts
$8.8M
Net Calls
-$669K
Net Calls Change
+$939K

Top Buyers

1
PA
Parallel Advisors
California
+$28.1M
2
NHAS
Novo Holdings A/S
Denmark
+$21.4M
3
Man Group
Man Group
United Kingdom
+$20M
4
BlackRock
BlackRock
New York
+$19.3M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$18.8M

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$17M
2
Millennium Management
Millennium Management
New York
-$14.1M
3
Invesco
Invesco
Georgia
-$8.02M
4
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$5.71M
5
N
Nuveen
North Carolina
-$4.36M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIM
176
CIM Investment Management
Pennsylvania
$246K – – –
XT
177
XTX Topco
Cayman Islands
$244K +$255K +9,520 New
Baird Financial Group
178
Baird Financial Group
Wisconsin
$241K +$252K +9,417 New
Nisa Investment Advisors
179
Nisa Investment Advisors
Missouri
$233K +$1.58K +59 +0.7%
PNC Financial Services Group
180
PNC Financial Services Group
Pennsylvania
$228K +$49.2K +1,837 +26%
Rafferty Asset Management
181
Rafferty Asset Management
New York
$221K -$65.1K -2,434 -22%
KBC Group
182
KBC Group
Belgium
$217K – – –
Wellington Management Group
183
Wellington Management Group
Massachusetts
$213K +$222K +8,309 New
JIR
184
James Investment Research
Ohio
$206K – – –
QT
185
Quantbot Technologies
New York
$195K +$118K +4,415 +137%
Royal Bank of Canada
186
Royal Bank of Canada
Ontario, Canada
$184K -$191K -7,148 -50%
AIP
187
Ameritas Investment Partners
Nebraska
$163K – – –
LSV Asset Management
188
LSV Asset Management
Illinois
$158K -$45.9K -1,714 -22%
Osaic Holdings
189
Osaic Holdings
Arizona
$142K +$20.9K +781 +16%
MLICM
190
Metropolitan Life Insurance Company (MetLife)
New York
$138K – – –
TRCT
191
Tower Research Capital (TRC)
New York
$119K +$36.2K +1,353 +41%
CIM
192
Chiron Investment Management
New York
$101K +$106K +3,957 New
VI
193
Vestcor Inc
New Brunswick, Canada
$95K +$99.1K +3,705 New
IA
194
IFP Advisors
Florida
$84K +$1.71K +64 +2%
Macquarie Group
195
Macquarie Group
Australia
$73K -$45.9K -1,716 -60%
Lazard Asset Management
196
Lazard Asset Management
New York
$59K -$5.19K -194 -8%
AS
197
Altshuler Shaham
Israel
$58K +$24.7K +922 +68%
FMP
198
Financial Management Professionals
Texas
$51K – – –
SWA
199
Sutton Wealth Advisors
Florida
$42.2K +$482 +18 +1%
QCG
200
Quadrant Capital Group
Ohio
$40K +$36.9K +1,378 +714%
6 7
8
9 10

CORT Hedge Fund Activity: Q3 2022 in Review

239 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Corcept Therapeutics (CORT) for Q3 2022, worth a combined $2.24B — up 11% from $2.02B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new CORT positions and 19 closed out — a net gain of 16 holders — while 91 added to existing stakes and 78 trimmed.

The largest buyer was Parallel Advisors, adding an estimated $28.1M. The largest seller was Renaissance Technologies, cutting an estimated $17M.

  • 239 institutional investors held Corcept Therapeutics (CORT) as of Q3 2022, up from 225 in Q2 2022.
  • Funds reported $2.24B of Corcept Therapeutics stock for Q3 2022, up 11% quarter-over-quarter.
  • 35 funds opened new Corcept Therapeutics positions in Q3 2022 and 19 closed out, a net change of +16 holders.
  • The largest Corcept Therapeutics buyer in Q3 2022 was Parallel Advisors, an estimated $28.1M added.
  • The largest Corcept Therapeutics seller in Q3 2022 was Renaissance Technologies, an estimated $17M sold.

Based on aggregated 13F filings for Q3 2022.